At the forefront of vascular access safety, Citra-Lock from Dirinco combines pure citrate with innovative anti-clotting and antimicrobial properties, recommended by the European Renal Best Practice Guidelines (ERBP) and the American Society of Diagnostic and Interventional Nephrology (ASDIN). Through our partnership, Transmedic has brought this trusted solution to hospitals and dialysis centres across the region, including one of Singapore’s largest cancer centres, where it is helping improve vascular access management and reduce complications. We empower healthcare teams to deliver safer, more effective care—ensuring that every patient benefits from the highest standards of treatment.